Plasma homocysteine concentration and its relation to symptoms of vascular disease in psychogeriatric patients

Dementia and Geriatric Cognitive Disorders

Volumn 20, Issue 1, 2005, Pages 35-41

  Nilsson, Karin ^a   Gustafson, Lars ^a   Hultberg, Björn ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Brain natriuretic peptide; Cobalamin; Creatinine; Cystatin C; Folate homocysteine; Protein S 100B; Psychogeriatric patients; Vascular disease

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; COBALAMIN; CREATININE; CYSTATIN C; FOLIC ACID; HOMOCYSTEINE; PROTEIN S100B;

ADULT; AGE DISTRIBUTION; AGED; AMINO ACID BLOOD LEVEL; AMINO TERMINAL SEQUENCE; ARTICLE; BRAIN INJURY; CLINICAL FEATURE; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; FOLIC ACID BLOOD LEVEL; GERIATRIC PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; SAMPLE SIZE; VASCULAR DISEASE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CREATININE; CYSTATINS; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROTEIN S; VASCULAR DISEASES; VITAMIN B 12;

EID: 22144448603     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000085072     Document Type: Article

References (28)

1. Nilsson K, Gustafson L, Fäldt R, Andersson A, Brattström L, Lindgren A, Israelsson B, Hultberg B: Hyperhomocysteinemia - A common finding in a psychogeriatric population. Eur J Clin Invest 1996;26:853-859.
2. Nilsson K, Gustafson L, Hultberg B: Plasma homocysteine is a sensitive marker for tissue deficiency of both cobalamins and folates in a psychogeriatric population. Dement Geriatr Cogn Disord 1999;10:476-482.
3. Nilsson K, Gustafson L, Hultberg B: The plasma homocysteine concentration is better than that of serum methylmalonic acid as a marker for sociopsychological performance in a psychogeriatric population. Clin Chem 2000;46:691-696.
4. Hultberg B, Isaksson A, Nilsson K, Gustafson L: Markers for the functional availability of cobalamin/folate and their association with neuropsychiatric symptoms in the elderly. Int J Geriatr Psychiatry 2001;16:873-878.
5. Lehmann M, Gottfries CG, Regland B: Identification of cognitive impairment in the elderly: Homocysteine is an early marker. Dement Geriatr Cogn Disord 1999;10:12-20.
6. Morris SM, Jacques PF, Rosenberg IH, Selhub J: Hyperhomocysteinemia associated with poor recall in the third National Health and Nutrition Examination Survey. Am J Clin Nutr 2001;73:927-933.
7. Nilsson K, Gustafson L, Hultberg B: Improvement of cognitive functions after cobalamin/folate supplementation in elderly patients with dementia and elevated plasma homocysteine. Int J Geriatr Psychiatry 2001;16:609-614.
8. Nilsson K, Gustafson L, Isaksson A, Hultberg B: Folate deficiency is a common finding in psychogeriatric patients. Aging Clin Exp Res 2002;14:479-484.
9. Nilsson K, Gustafson L, Hultberg B: Role of impaired renal function as a cause of elevated plasma homocysteine concentration in psychogeriatric patients. Scand J Clin Lab Invest 2002;62:385-390.
10. Refsum H, Ueland PM, Nygård O, Vollset SE: Homocysteine and cardiovascular disease. Annu Rev Med 1998;49:31-62.
11. Mudd SH, Levy HL, Skovby F: Disorders of transsulfuration; in Scriver CR, Beaudet AL, Sly WS, Valle D (eds): The Metabolic and Molecular Basis of Inherited Disease, ed 7. New York, McGraw-Hill Book Co, 1995, pp 1279-1327.
12. Bottiglieri T: Folate, vitamin B-12 and neuropsychiatric disorders. Nutr Rev 1996;54:382-390.
13. Nilsson K, Gustafson L, Hultberg B: Relation between plasma homocysteine and Alzheimer's disease. Dement Geriatr Cogn Disord 2002;14:7-12.
14. Talwar S, Squire IB, Davies JE, Barnett DB, Ng LL: Plasma N-terminal pro-brain natriuretic peptide and ECG in the assessment of left-ventricular systolic dysfunction in a high risk population. Eur Heart J 1999;20:1736-1744.
15. Johnston N, Jernberg T, Lindahl B, Lindbäck J, Stridsberg M, Larsson A, Venge P, Wallentin L: Biochemical indicators of cardiac and renal function in a healthy population. Clin Biochem 2004;37:210-216.
16. Lamers KJ, Vos P, Verbeek MM, Rosmalen F, van Geel WJA, van Engelen BGM: Protein S-100B, neuron-specific enolase (NSE), myelin basic protein (MBP) and glial fibrillary acidic protein (GFAP) in cerebrospinal fluid (CSF) and blood of neurological patients. Brain Res Bull 2003;61:261-264.
17. Herrman M, Vos P, Wunderlich MT, de Bruijn CHMM, Lamers KJB: Release of glial tissue specific proteins after acute stroke: A comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein. Stroke 2000;31:2670-2677.
18. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E: Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol 1999;56:303-308.
19. Nilsson K, Gustafson L, Fäldt R, Andersson A, Hultberg B: Plasma homocysteine in relation to serum cobalamin and blood folate in a psychogeriatric population. Eur J Clin Invest 1994;24:600-606.
20. Nilsson K, Gustafson L, Fäldt R, Andersson A, Vaara I, Nilsson R, Alm B, Hultberg B: Plasma methylmalonic acid in relation to serum cobalamin and plasma homocysteine in a psychogeriatric population and the effect of cobalamin treatment. Int J Geriatr Psychiatry 1997;12:62-72.
21. Andersson A, Isaksson A, Brattström L, Hultberg B: Homocysteine and other thiols determined in plasma by HPLC and thiol-specific post-column derivatization. Clin Chem 1993;39:1590-1597.
22. Nilsson K, Gustafson L, Hultberg B: Optimal use of markers for cobalamin and folate status in a psychogeriatric population. Int J Geriatr Psychiatry 2002;17:919-925.
23. Nilsson K, Gustafson L, Hultberg B: Plasma homocysteine concentration relates to the severity but not to the duration of Alzheimer's disease. Int J Geriatr Psychiatry 2004;19:666-672.
24. Wallin A, Blennow K, Gottfries C G, Långström G, Uhlemann C: White matter low attenuation on computed tomography in Alzheimer's disease and vascular dementia. Acta Neurol Scand 1989;80:518-523.
25. Englund E, Brun A, Gustafson L: A white-matter disease in dementia of Alzheimer type: Clinical and neuropathological correlates. Int J Geriatr Psychiatry 1989;4:87-102.
26. Diagnostic and Statistical Manual of Mental Disorders, ed 3 rev., DSM-III-R. Washington, American Psychiatric Association, 1987, pp 103-107.
27. Hall C: Essential biochemistry and physiology of (NT-pro)BNP. Eur J Heart Fail 2004;6:257-260.
28. Jonsson H, Johnsson P, Hoglund P, Alling C, Blomquist S: Elimination of S100B and renal function after cardiac surgery. J Cardiothorac Vasc Anesth 2000;14:698-701.